Intact Vascular Stock

intactvascular.comHealthcare / Medical DevicesFounded: 2011Funding to Date: $111.19MM

Intact Vascular is a medical device company that develops minimally invasive peripheral vascular products.

Register To Buy and Sell Shares

For more details on financing and valuation for Intact Vascular, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Intact Vascular’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Intact Vascular.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Peter Schneider MD
Co-Founder, Chief Medical Officer & Board Member
Michael Longo
Vice President, Research & Development
Jim Harrison
Director, Implant Research & Development
Howard Rosen
Vice President of Marketing & Business Development
Monica Klos
Marc Penna
Vice President of Clinical Affairs
Joseph Griffin III
Vice President of Regulatory Affairs & Quality Assurance and Compliance Officer
Bruce Shook
President, Chief Executive Officer & Board Member

Board Members

Dennis Wahr MD
Justin Klein MD
New Enterprise Associates
Douglas Evans
Peter Schneider MD
Bruce Robertson Ph.D
H.I.G. BioHealth Partners
Sherrill Neff JD
Quaker Partners
Joshua Makower MD

News Highlights

Philips Acquires Intact Vascular, For Up To $360M | FinSMEs
Intact Vascular, a Wayne, PA based company that develops medical devices for minimally invasive peripheral vascular procedures, has been acquired by Royal Philips
Updated on: Apr 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.